| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Alseroxylon |
Is a |
True |
Rauwolfia alkaloid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Reserpine - chemical |
Is a |
False |
Rauwolfia alkaloid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Rauwolfia antihypertensive adverse reaction |
Causative agent (attribute) |
False |
Rauwolfia alkaloid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Rauwolfia antihypertensive allergy |
Causative agent (attribute) |
False |
Rauwolfia alkaloid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Poisoning by rauwolfia alkaloid |
Causative agent (attribute) |
True |
Rauwolfia alkaloid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Reserpine/rauwolfia alkaloids |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rauwolfia alkaloid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely rauwolfia alkaloid 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rauwolfia alkaloid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely rauwolfia alkaloid 100 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rauwolfia alkaloid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Reserpine |
Is a |
True |
Rauwolfia alkaloid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Rauwolfia alkaloid-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Rauwolfia alkaloid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Yohimbine |
Is a |
True |
Rauwolfia alkaloid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Rauwolfia antihypertensive allergy |
Causative agent (attribute) |
False |
Rauwolfia alkaloid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Raubasine |
Is a |
True |
Rauwolfia alkaloid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Deserpidine (substance) |
Is a |
True |
Rauwolfia alkaloid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely rauwolfia alkaloid 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rauwolfia alkaloid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely rauwolfia alkaloid 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Rauwolfia alkaloid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely rauwolfia alkaloid 100 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rauwolfia alkaloid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely rauwolfia alkaloid 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Rauwolfia alkaloid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing rauwolfia alkaloid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Rauwolfia alkaloid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely rauwolfia alkaloid 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Rauwolfia alkaloid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely rauwolfia alkaloid 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Rauwolfia alkaloid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Yohimbine hydrochloride (substance) |
Is a |
True |
Rauwolfia alkaloid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing only rauwolfia alkaloid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Rauwolfia alkaloid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Rauwolfia alkaloid only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Rauwolfia alkaloid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Allergy to rauwolfia alkaloid |
Causative agent (attribute) |
True |
Rauwolfia alkaloid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Adverse reaction caused by rauwolfia alkaloid (disorder) |
Causative agent (attribute) |
True |
Rauwolfia alkaloid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]